6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Tsarkakewa

6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 Tsafta ≥99.0% Favipiravir Matsakaici COVID-19

Takaitaccen Bayani:

Suna: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

Saukewa: 259793-88-9

Tsafta: ≥99.0%

Matsakaicin Favipiravir (CAS 259793-96-9) a cikin maganin cututtukan mura da COVID-19

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Mai ƙera tare da Babban Tsafta da Ƙarfin Ƙarfi
Samar da Kasuwancin Favipiravir da Matsakaici masu alaƙa:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Abubuwan Sinadarai:

Sunan Sinadari	6-Bromo-3-Hydroxypyrazine-2-Carboxamide
Makamantu	Favipiravir Matsakaici;Favipiravir 4
Lambar CAS	259793-88-9
Lambar CAT	Saukewa: RF-PI296
Matsayin Hannun jari	A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram
Tsarin kwayoyin halitta	Saukewa: C5H4BrN3O2
Nauyin Kwayoyin Halitta	218.01
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Rawaya Mai Haske zuwa Foda Brown
Ganewa	IR, HPLC
Asara akan bushewa	≤1.0%
Ragowa akan Ignition	≤0.20%
Tsaftace Guda Daya	≤0.50%
Jimlar ƙazanta	≤1.0%
Karfe masu nauyi	≤20ppm
Ragowar Magani	Haɗu da ƙayyadaddun bayanai
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaicin Favipiravir (CAS 259793-96-9)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

FAQ:

Aikace-aikace:

6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) matsakaita ne yawanci a cikin haɗin 6-Bromo-3-Hydroxypyrazine-2-Carboxamide mai suna Favipiravir (CAS 259793-96-9) maganin cututtukan mura.Hanya mai amfani da matakin tattalin arziki zuwa Favipiravir.Favipiravir samfurin bincike ne mai alaƙa da COVID19, a cikin kula da marasa lafiya tare da COVID-19 wanda WHO ta ba da shawarar.Favipiravir, wanda kuma aka sani da T-705 ko Avigan, maganin rigakafi ne wanda Toyama Chemical (Rukunin Fujifilm) na Japan ke haɓaka tare da aiki akan ƙwayoyin cuta na RNA da yawa.An amince da Favipiravir don tallace-tallace a Japan a cikin Maris 2014 kuma an yi amfani da shi don maganin rigakafi na mura A da B. Baya ga kwayar cutar mura, miyagun ƙwayoyi kuma ya nuna kyakkyawan aikin rigakafi ga ƙwayoyin cuta na RNA iri-iri, irin su cutar Ebola, ƙwayar yashi. A watan Fabrairun 2020 ana nazarin Favipiravir a China don gwajin gwajin cutar COVID-19 (Novel Coronavirus) kuma ya nuna sakamako mai kyau.